Natralbio New Materials

Natralbio is a synthetic biology-driven biotechnology company focused on the research, development, and industrialization of recombinant humanized collagen and other advanced biomaterials. The company utilizes high-efficiency microbial expression systems to produce collagen that is highly homologous to human sequences, ensuring superior biocompatibility and biological activity compared to animal-derived alternatives. Their products are primarily applied in medical aesthetics, professional skincare, and regenerative medicine, including the development of Class III medical devices for tissue filling and repair. Natralbio's core technology platform enables the precise design of collagen sequences to target specific biological functions, such as cell adhesion and extracellular matrix remodeling. Based in Suzhou, China, the company has established large-scale GMP manufacturing capabilities to support its growing pipeline of medical and aesthetic products.